For research and educational purposes only. Not medical advice.
Adrafinil Reference
Educational, not medical advice reference for Adrafinil: Nootropic; regulatory status, evidence posture, source review, and schedule notes. Also known as Olm…
Reference summary
Older French clinical literature in elderly attention / vigilance trials. Pharmacology is dominated by hepatic conversion to modafinil.
- Categories
- Nootropic
- Aliases
- Olmifon, Modafinil prodrug
- Evidence posture
- human — Not FDA-approved. Withdrawn from the French market in 2011. Hepatic conversion to modafinil makes the practical effect modafinil-equivalent at higher doses. Liver-enzyme elevation has been reported with chronic adrafinil use.
- Regulatory status
- No FDA-approved adrafinil drug label. Withdrawn from the French market in 2011. Sold in the US as a research chemical / dietary supplement; metabolizes to modafinil in the liver. Not currently controlled in the US.
- Content review status
- research reference